Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ENDO PHARMACEUTICALS HLDGS I Analyst Recommendations

  • Analyst Consensus: ENDP

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.200 Buy 25
    30 Days Ago 2.200 Buy 25
    60 Days Ago 2.360 Buy 25
    90 Days Ago 2.417 Buy 24
    120 Days Ago 2.542 Hold 24
  • Analyst Ratings: ENDP

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Oppenheimer Perform Outperform 10/04/2009 27.00
    Jefferies & Co Buy 10/02/2009 30.00
    Piper Jaffray Neutral Overweight 07/31/2009
    Jefferies & Co Hold 07/31/2009 22.00
    Citigroup Buy 07/20/2009
    Thomas Weisel Overweight 06/01/2009 24.00
    UBS Neutral 04/30/2009 18.00
    Oppenheimer Outperform Perform 04/29/2009
    RBC Capital Mkts Sector Perform 04/22/2009 21.00
    Wedbush Morgan Hold 03/26/2009
    Caris & Company Average Above Average 03/16/2009 21.00
    Piper Jaffray Neutral 03/12/2009
    Roth Capital Hold 03/05/2009 24.00
    Credit Suisse Neutral 02/25/2009
    Cowen & Co Outperform Neutral 01/06/2009
    Caris & Company Above Average Average 01/06/2009 21.00
    Caris & Company Buy Above Average 01/05/2009
    Oppenheimer Outperform 12/18/2008 28.00
    Soleil Buy 12/11/2008 28.00
    Caris & Company Buy 11/21/2008
    RBC Capital Mkts Sector Perform Outperform 10/31/2008
    Stanford Research Buy 09/24/2008 28.00
    UBS Neutral Buy 09/15/2008
    Caris & Company Above Average 08/21/2008 28.00
    RBC Capital Mkts Sector Perform 07/21/2008 30.00
    Roth Capital Buy Hold 05/02/2008 28.00
    Lehman Brothers Overweight 05/01/2008 38.00
    Robert W. Baird Outperform Neutral 05/01/2008 31.00
    Susquehanna Financial Neutral Positive 03/27/2008
    Roth Capital Hold Buy 03/06/2008 34.00